🇪🇺 PF-06804103 + Palbociclib +Letrozole in European Union

PF-06804103 + Palbociclib +Letrozole (pf-06804103-palbociclib-letrozole) regulatory status in European Union.

Marketing authorisation

EMA

  • Local brand name: PF-06804103 + Palbociclib +Letrozole
  • Status: approved

Other Oncology approved in European Union

Frequently asked questions

Is PF-06804103 + Palbociclib +Letrozole approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for PF-06804103 + Palbociclib +Letrozole in European Union?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.